Randomised clinical trial: a leucine‐metformin‐sildenafil combination (NS‐0200) vs placebo in patients with non‐alcoholic fatty liver disease

BACKGROUND: Sirtuin 1 (Sirt1) is suppressed in non‐alcoholic fatty liver disease (NAFLD), while its’ stimulation or overexpression results in reduced disease severity in pre‐clinical NAFLD models. Leucine allosterically activates Sirt1 and synergise with other Sirt/AMPK/NO pathway activators. We dev...

Descripción completa

Detalles Bibliográficos
Autores principales: Chalasani, N., Vuppalanchi, R., Rinella, M., Middleton, M. S., Siddiqui, M. S., Barritt, A. S., Kolterman, O., Flores, O., Alonso, C., Iruarrizaga‐Lejarreta, M., Gil‐Redondo, R., Sirlin, C. B., Zemel, M. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Randomised Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001629/
https://www.ncbi.nlm.nih.gov/pubmed/29696666
http://dx.doi.org/10.1111/apt.14674

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6001629/
https://www.ncbi.nlm.nih.gov/pubmed/29696666
http://dx.doi.org/10.1111/apt.14674

Ejemplares similares